Effects of chemically modified tetracyclines on iNOS in mesangial cells: impact on experimental glomerulonephritis.
Trachtman
H
H
Schneider Children's Hospital, Division of Nephrology, New Hyde Park, New York 11040-1432, USA.
D000818:Animals; D000961:Antilymphocyte Serum; D002478:Cells, Cultured; D015971:Gene Expression Regulation, Enzymologic; D005920:Glomerular Mesangium / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology*; D005921:Glomerulonephritis / Q000201:enzymology* / Q000209:etiology / Q000473:pathology; D006801:Humans; D008297:Male; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D011507:Proteinuria; D051381:Rats; D017207:Rats, Sprague-Dawley; D013754:Tetracyclines / Q000494:pharmacology*